| Generation and culture of osteoclasts S Marino, JG Logan, D Mellis, M Capulli BoneKEy reports 3, 2014 | 137 | 2014 |
| In vitro enhancement of anticancer activity of paclitaxel by a Cremophor free cyclodextrin-based nanosponge formulation B Mognetti, A Barberis, S Marino, G Berta, S De Francia, F Trotta, ... Journal of Inclusion Phenomena and Macrocyclic Chemistry 74, 201-210, 2012 | 125 | 2012 |
| Multiple myeloma and bone: The fatal interaction S Marino, GD Roodman Cold Spring Harbor perspectives in medicine 8 (8), a031286, 2018 | 49 | 2018 |
| Models of ex vivo explant cultures: applications in bone research S Marino, KA Staines, G Brown, RA Howard-Jones, M Adamczyk BoneKEy reports 5, 2016 | 49 | 2016 |
| Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture B Mognetti, S Marino, A Barberis, AS Bravo Martin, Y Bala, F Di Carlo, ... Calcified tissue international 89, 163-171, 2011 | 47 | 2011 |
| Combined deficiency of the Cnr1 and Cnr2 receptors protects against age‐related bone loss by osteoclast inhibition A Sophocleous, S Marino, D Kabir, SH Ralston, AI Idris Aging Cell 16 (5), 1051-1061, 2017 | 46 | 2017 |
| Emerging therapeutic targets in cancer induced bone disease: a focus on the peripheral type 2 cannabinoid receptor S Marino, AI Idris Pharmacological Research 119, 391-403, 2017 | 39 | 2017 |
| Preferential killing of cancer cells using silicon carbide quantum dots B Mognetti, A Barberis, S Marino, F Di Carlo, V Lysenko, O Marty, ... Journal of Nanoscience and Nanotechnology 10 (12), 7971-7975, 2010 | 38 | 2010 |
| Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer-induced osteolysis A Sophocleous, S Marino, JG Logan, P Mollat, SH Ralston, AI Idris Journal of Biological Chemistry 290 (36), 22049-22060, 2015 | 35 | 2015 |
| Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice S Marino, D de Ridder, RT Bishop, N Renema, M Ponzetti, ... EBioMedicine 44, 452-466, 2019 | 32 | 2019 |
| 2D and 3D in vitro co-culture for cancer and bone cell interaction studies S Marino, RT Bishop, D de Ridder, J Delgado-Calle, MR Reagan Bone Research Protocols, 71-98, 2019 | 31 | 2019 |
| Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial S Lanfranconi, E Scola, JMTA Meessen, R Pallini, GA Bertani, ... The Lancet Neurology 22 (1), 35-44, 2023 | 30 | 2023 |
| TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis P Peramuhendige, S Marino, RT Bishop, D de Ridder, A Khogeer, ... Scientific reports 8 (1), 39, 2018 | 28 | 2018 |
| Therapeutic targets in myeloma bone disease S Marino, DN Petrusca, GD Roodman British Journal of Pharmacology 178 (9), 1907-1922, 2021 | 26 | 2021 |
| Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis RT Bishop, S Marino, G Carrasco, B Li, RJ Allen, A Sparatore, PD Ottewell, ... Cancer letters 488, 27-39, 2020 | 25 | 2020 |
| XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome … J Adamik, R Silbermann, S Marino, Q Sun, JL Anderson, D Zhou, XQ Xie, ... Frontiers in Endocrinology 9, 344, 2018 | 21 | 2018 |
| Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer RT Bishop, S Marino, D de Ridder, RJ Allen, DV Lefley, AH Sims, N Wang, ... Cancer letters 450, 76-87, 2019 | 20 | 2019 |
| Selective tyrosine kinase inhibition of insulin‐like growth factor‐1 receptor inhibits human and mouse breast cancer–induced bone cell activity, bone remodeling, and osteolysis JG Logan, A Sophocleous, S Marino, M Muir, VG Brunton, AI Idris Journal of Bone and Mineral Research 28 (5), 1229-1242, 2013 | 18 | 2013 |
| Pharmacological inhibition of NFκB reduces prostate cancer related osteoclastogenesis in vitro and osteolysis ex vivo S Marino, RT Bishop, G Carrasco, JG Logan, B Li, AI Idris Calcified tissue international 105, 193-204, 2019 | 17 | 2019 |
| Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis S Marino, RT Bishop, JG Logan, P Mollat, AI Idris Cancer letters 410, 180-190, 2017 | 13 | 2017 |
